Fig. 3From: Delayed onset of neurosarcoidosis after concurrent ipilimumab/nivolumab therapyBrain MRI obtained 4 months after starting methotrexate in setting of neurological improvement. T1-weighted contrast-enhanced axial image through the parieto-occipital region shows resolution of leptomeningeal enhancementBack to article page